• A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred

    29 days ago - By Medscape

    On the heels of the DAPA-HF outcomes trial, DEFINE-HF shows adding the SGLT-2 inhibitor to standard meds improved other endpoints heart failure patients care about, whether or not they had diabetes.
    Medscape Medical News
    Read more ...